Preclinical tests on novel Covid-19 vaccines

Press/Media: Public Engagement ActivitiesPopular

Description

Geert van den BogaartGeert van den Bogaart

The research group Molecular Immunology and Microbiology headed by Prof.dr. Geert van den Bogaart collaborates with the German company BaseClick to pre-clinically test new RNA-based coronavirus vaccines. For this, isolated immune cells from blood of healthy volunteers are studied to determine whether the vaccines correctly initiate the anti-viral immune response. This research specifically focuses on the activation of T-cells to recognize the Covid-19 virus.
Read more on the program

Period22-Jun-2020

Media coverage

1

Media coverage

  • TitlePreclinical tests on novel Covid-19 vaccines
    Degree of recognitionInternational
    Media name/outletUniversity of Groningen News on Covid-19 related research
    Media typeWeb
    Country/TerritoryNetherlands
    Date22/06/2020
    DescriptionThe research group Molecular Immunology and Microbiology headed by Prof.dr. Geert van den Bogaart collaborates with the German company BaseClick to pre-clinically test new RNA-based coronavirus vaccines. For this, isolated immune cells from blood of healthy volunteers are studied to determine whether the vaccines correctly initiate the anti-viral immune response. This research specifically focuses on the activation of T-cells to recognize the Covid-19 virus.
    Read more on the program
    URLhttps://www.rug.nl/research/corona-publicaties/
    PersonsGeert van den Bogaart